Why the study?
Current mechanical and biological prosthetic valves have significant long-term limitations, and translating tissue-engineered heart valves into viable, fully biocompatible clinical solutions remains elusive.
Design
Review
Authors
Loading...
These animal findings remain preclinical; leaves open translation to pharmacological or prosthetic valve therapies in patients.
Tissue engineered heart valves offer the potential for living, self-repairing valve replacements, though significant challenges in mechanical durability and long-term biocompatibility remain before widespread clinical translation.
Ragazzini et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: